Related Experiment Videos
Hypertension and myocardial ischemia
Brian P Murphy1, Tony Stanton, Francis G Dunn
1Cardiac Department, Stobhill Hospital, Glasgow, Scotland, UK.
Insights
Hypertension significantly increases the risk of myocardial ischemia through various mechanisms, impacting the heart
Area of Science:
- Cardiology
- Internal Medicine
- Vascular Biology
Background:
- Hypertension is a major risk factor for cardiovascular diseases.
- A strong evidence base links hypertension to myocardial ischemia over 30 years.
- Mechanisms include coronary artery disease, hemodynamic, microcirculatory, and neuroendocrine factors.
Purpose of the Study:
- To review the relationship between hypertension and myocardial ischemia.
- To highlight diagnostic tools for assessing ischemia in hypertensive patients.
- To emphasize risk reduction strategies.
Main Methods:
- Review of existing scientific literature and studies.
- Analysis of pathophysiological mechanisms linking hypertension and ischemia.
- Discussion of diagnostic modalities for myocardial ischemia detection.
Main Results:
- Hypertension destabilizes myocardial oxygen supply and demand balance.
- Various factors contribute to ischemia in hypertensive individuals.
- Sophisticated investigations can detect and quantify myocardial ischemia.
Conclusions:
- Effective management of hypertension and cardiovascular risk factors is crucial.
- Targeted therapies can mitigate the clinical sequelae of myocardial ischemia.
- Reducing blood pressure minimizes risks in hypertensive patients prone to ischemia.
Abstract:
Detailed studies over the past 30 years have built up an impressive evidence base for the presence of myocardial ischemia in patients who have hypertension. This relationship ranges from the obvious association with obstructive coronary artery disease to mechanisms related to hemodynamic, microcirculatory, and neuroendocrine abnormalities. All of these factors serve to destabilize the critical balance between myocardial oxygen supply and demand. We have at our disposal a range of sophisticated investigations that allow us to demonstrate the presence and extent of the ischemia and therefore to target specific therapies to reduce the risk to these patients. Achieving target BP and managing all reversible components of the patient's cardiovascular risk status reduce to a minimum the clinical sequelae of myocardial ischemia in this vulnerable population..
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy